SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227692
Filing Date
2023-09-01
Accepted
2023-09-01 16:36:00
Documents
13
Period of Report
2023-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d540978d8k.htm   iXBRL 8-K 31565
2 EX-10.1 d540978dex101.htm EX-10.1 576490
  Complete submission text file 0001193125-23-227692.txt   863913

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA biib-20230828.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20230828_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20230828_pre.xml EX-101.PRE 10818
7 EXTRACTED XBRL INSTANCE DOCUMENT d540978d8k_htm.xml XML 3204
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 231233044
SIC: 2836 Biological Products, (No Diagnostic Substances)